August 2020

BARDA and NOWDiagnostics come together to expand a COVID-19 antibody fast to be used at the point of service and at home

NOWDiagnosiss, Inc. announced today that it is running with BARDA, the branch of the U.S. Department of Health and Human Services’s Advanced Biomedical Research and Development Authority.To expand a serological control of ANTI-SARS-CoV-2 antibodies that can be used in a variety of health care services, from clinics to hospital emergency rooms, and finally through consumers for home use.

BARDA and NOWDiagnostics come together to expand a COVID-19 antibody fast to be used at the point of service and at home Read More »